Innovative MedTech Inc. (IMTH)
USD 0.43
(0.0%)
USD 0.43
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | -4.27 Million USD | -17.93% |
| 2023 | -3.62 Million USD | 80.15% |
| 2022 | -18.25 Million USD | -2475.64% |
| 2021 | -708.87 Thousand USD | -87.35% |
| 2020 | -378.37 Thousand USD | -79.28% |
| 2019 | -211.05 Thousand USD | 0.0% |
| 2014 | -335.96 Thousand USD | -18.18% |
| 2013 | -284.27 Thousand USD | 79.98% |
| 2012 | -1.42 Million USD | -57.17% |
| 2011 | -903.54 Thousand USD | 26.96% |
| 2010 | -1.23 Million USD | -87.34% |
| 2009 | -660.29 Thousand USD | 51.55% |
| 2008 | -1.36 Million USD | -28.98% |
| 2007 | -1.05 Million USD | -68.06% |
| 2006 | -628.8 Thousand USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q4 | -3.06 Million USD | -240.19% |
| 2024 Q3 | -902.01 Thousand USD | -475.44% |
| 2024 Q2 | -156.75 Thousand USD | -6.77% |
| 2024 Q1 | -146.8 Thousand USD | 81.8% |
| 2023 Q2 | -932.4 Thousand USD | 3.18% |
| 2023 Q1 | -963 Thousand USD | 94.53% |
| 2023 FY | -3.62 Million USD | 80.15% |
| 2023 Q4 | -806.73 Thousand USD | 12.51% |
| 2023 Q3 | -922.1 Thousand USD | 1.1% |
| 2022 FY | -18.25 Million USD | -2475.64% |
| 2022 Q4 | -17.61 Million USD | -8974.28% |
| 2022 Q3 | -194.17 Thousand USD | -33.11% |
| 2022 Q2 | -145.87 Thousand USD | 51.08% |
| 2022 Q1 | -298.15 Thousand USD | -54.76% |
| 2021 Q1 | -33.27 Thousand USD | 0.0% |
| 2021 Q4 | -192.66 Thousand USD | 52.58% |
| 2021 Q2 | -76.65 Thousand USD | -130.4% |
| 2021 Q3 | -406.29 Thousand USD | -430.03% |
| 2021 FY | -708.87 Thousand USD | -87.35% |
| 2020 FY | -378.37 Thousand USD | -79.28% |
| 2019 FY | -211.05 Thousand USD | 0.0% |
| 2015 Q1 | -110.62 Thousand USD | -88.63% |
| 2014 Q1 | -58.78 Thousand USD | 0.0% |
| 2014 Q4 | -58.65 Thousand USD | -1.28% |
| 2014 Q3 | -57.9 Thousand USD | 46.77% |
| 2014 FY | -335.96 Thousand USD | -18.18% |
| 2014 Q2 | -108.78 Thousand USD | -85.06% |
| 2013 FY | -284.27 Thousand USD | 79.98% |
| 2013 Q4 | -58.78 Thousand USD | -0.86% |
| 2013 Q1 | -739.07 Thousand USD | -353.26% |
| 2013 Q2 | -108.43 Thousand USD | 85.33% |
| 2013 Q3 | -58.28 Thousand USD | 46.25% |
| 2012 Q2 | -284.02 Thousand USD | -189.17% |
| 2012 FY | -1.42 Million USD | -57.17% |
| 2012 Q4 | -163.05 Thousand USD | 29.93% |
| 2012 Q3 | -232.71 Thousand USD | 18.07% |
| 2012 Q1 | -98.22 Thousand USD | 40.17% |
| 2011 Q1 | -562.97 Thousand USD | -79.65% |
| 2011 FY | -903.54 Thousand USD | 26.96% |
| 2011 Q4 | -164.16 Thousand USD | 57.17% |
| 2011 Q3 | -383.3 Thousand USD | -48.65% |
| 2011 Q2 | -257.85 Thousand USD | 54.2% |
| 2010 FY | -1.23 Million USD | -87.34% |
| 2010 Q1 | -88.66 Thousand USD | 29.92% |
| 2010 Q2 | -144.87 Thousand USD | -63.4% |
| 2010 Q3 | -174.79 Thousand USD | -20.66% |
| 2010 Q4 | -313.36 Thousand USD | -79.28% |
| 2009 Q1 | -264.89 Thousand USD | 35.1% |
| 2009 Q4 | -126.52 Thousand USD | 59.54% |
| 2009 Q3 | -312.72 Thousand USD | -103.62% |
| 2009 Q2 | -153.58 Thousand USD | 42.02% |
| 2009 FY | -660.29 Thousand USD | 51.55% |
| 2008 Q2 | -465.6 Thousand USD | -30.4% |
| 2008 Q1 | -357.05 Thousand USD | -5.29% |
| 2008 Q3 | -224.28 Thousand USD | 51.83% |
| 2008 Q4 | -408.18 Thousand USD | -81.99% |
| 2008 FY | -1.36 Million USD | -28.98% |
| 2007 Q3 | -142.47 Thousand USD | 34.68% |
| 2007 Q4 | -339.1 Thousand USD | -138.01% |
| 2007 FY | -1.05 Million USD | -68.06% |
| 2007 Q1 | 308.6 Thousand USD | 428.7% |
| 2007 Q2 | -218.12 Thousand USD | -170.68% |
| 2006 Q3 | -344.39 Thousand USD | 35.09% |
| 2006 Q2 | -530.58 Thousand USD | 0.0% |
| 2006 Q4 | -93.88 Thousand USD | 72.74% |
| 2006 FY | -628.8 Thousand USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| American Medical Technologies Inc. | 1.16 Million USD | 467.119% |
| Ansell Limited | 129.3 Million USD | 103.306% |
| Ansell Limited | 129.3 Million USD | 103.306% |
| BG Medicine, Inc. | - USD | Infinity% |
| Biotage AB (publ) | 31.13 Million USD | 113.726% |
| BioLife Sciences Inc. | - USD | Infinity% |
| CB Scientific, Inc. | -1.59 Million USD | -167.849% |
| Psykey, Inc. | -797.5 Thousand USD | -435.932% |
| ConvaTec Group Plc | 262.7 Million USD | 101.627% |
| ConvaTec Group Plc | 262.7 Million USD | 101.627% |
| Encision Inc. | -640.78 Thousand USD | -567.008% |
| Golden Valley Development, Inc | -141.81 Thousand USD | -2913.945% |
| Hear AtLast Holdings, Inc. | -109.93 Thousand USD | -3787.998% |
| LifePoint, Inc. | -7.49 Million USD | 42.976% |
| Medite Cancer Diagnostics, Inc. | -6.48 Million USD | 34.042% |
| Paradigm Medical Industries, Inc. | 330 Thousand USD | 1395.175% |
| QuantRx Biomedical Corporation | - USD | Infinity% |
| Remedent, Inc. | -122.89 Thousand USD | -3377.969% |
| Reflect Scientific, Inc. | -467.27 Thousand USD | -814.675% |
| SmileDirectClub, Inc. | -241.15 Million USD | 98.228% |
| Sector 10, Inc. | -39.84 Thousand USD | -10627.025% |
| Shandong Weigao Group Medical Polymer Company Limited | 319.6 Million USD | 101.337% |
| SheerVision, Inc. | 155.72 Thousand USD | 2844.613% |
| United Health Products, Inc. | -2.42 Million USD | -76.139% |
| Vasamed, Inc. | 4.74 Million USD | 190.127% |
| Wearable Health Solutions, Inc. | -2.29 Million USD | -86.304% |
| Yubo International Biotech Limited | -1.2 Million USD | -254.629% |